Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease
Ruihua Sun, Yu Du · 2026
Read Development and validation of a clinical-pharmacogenomic prediction model for clopidogrel-related high on-treatment platelet reactivity in patients with coronary artery disease by Ruihua Sun, Yu Du (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13584308.txt.
Description
Ruihua Sun and Yu Du build a model to spot patients whose platelets stay too active on a common blood thinner in work dated two thousand twenty-six. The drug, clopidogrel, fails to calm platelets in some heart patients, which raises clot risk. A forecast before test results arrive could flag who needs early checks or a drug change.
Records of three hundred eighty heart patients were split into build and check sets. Seven core traits survived screening, among them a gene variant that cuts the drug's activation. Four models were built and compared on accuracy, calibration, and clinical worth. Explanations of each score's drivers were added through a standard attribution method.
Catalog record
| CREATOR | Ruihua Sun, Yu Du |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |